PRESS RELEASE | Basel, Switzerland, October 4, 2021

Versameb at Sachs 21st Annual Biotech in Europe Forum

  • Isabel Ferreira speaking on the “Platform Technologies and Novel Therapeutics” Panel

Versameb AG (“Versameb”), a pre-clinical stage company focused on discovering and developing innovative RNA-based drugs, today announces its participation in the  21st Annual Biotech in Europe Forum organized by SACHS Associates taking place virtually 7th-8th October 2021.

Isabel Ferreira, Chief Business Officer of Versameb AG will be participating in a panel discussion titled “Platform Technologies & Novel Therapeutics” taking place at 14.40 CET on 7th October 2021 and chaired by Bibhash Mukhopadhyay, Independent and Stefan Luzi, Partner at Gilde Healthcare Partners. Other panelists include Frauke Hein, Co-Founder & CBO, Adrenomed AG, Lynn Durham, Founder & CEO, STALICLA SA, Mike Romanos, Co-Founder & CEO, Microbiotica Ltd. and Yochi Slonim, Co-Founder & CEO, Anima Biotech, Inc.

Contact for media enquiries:

Dr Klaas Zuideveld, CEO

Optimum Strategic Communications
Mary Clark, Stella Lempidaki, Zoe Bolt
Tel: +44 (0)20 3950 9144